HIV Treatment Adherence Dose Determination Trial

Recruiting now · Not applicable

Conditions studied: HIV Infections

In brief

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.

Key facts

Study ID

NCT04577313

Run by

University of Connecticut

People needed

400

Starts

2020-09-01

Expected to finish

2026-11-30

Last updated by the study team

2025-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed HIV positive
• Confirmed prescribed antiretroviral therapy
• Confirmed non-adherent to anti-retroviral therapy

You may not qualify if…

• Does not have access to a phone
• Does not have access to the internet

Where it is running

• University of Connecticut — Storrs, Connecticut, United States (enrolling)
• University of Connecticut Field Site — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.